Implications of Standardized Uptake Values of Oral Squamous Cell Carcinoma in PET-CT on Prognosis, Tumor Characteristics and Mitochondrial DNA Heteroplasmy.

18[F]FDG-PET-CT mitochondrial DNA heteroplasmy oral squamous cell carcinoma standardized uptake values

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
10 May 2021
Historique:
received: 15 03 2021
revised: 17 04 2021
accepted: 05 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 3 6 2021
Statut: epublish

Résumé

Under aerobic conditions, some cancers switch to glycolysis to cover their energy requirements. Taking advantage of this process, functional imaging techniques such as PET-CT can be used to detect and assess tumorous tissues. The aim of this study was to investigate standardized uptake values and mitochondrial DNA mutations in oral squamous cell carcinoma. A cohort of 57 patients underwent

Identifiants

pubmed: 34068489
pii: cancers13092273
doi: 10.3390/cancers13092273
pmc: PMC8125984
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Ann Thorac Surg. 2006 Aug;82(2):417-22; discussion 422-3
pubmed: 16863739
Biology (Basel). 2020 Feb 02;9(2):
pubmed: 32024247
Oncotarget. 2017 Jun 29;8(38):63715-63723
pubmed: 28969023
Nature. 1981 Apr 9;290(5806):457-65
pubmed: 7219534
Oncotarget. 2012 Jul;3(7):670-7
pubmed: 22832574
Am J Hum Genet. 2010 Dec 10;87(6):802-12
pubmed: 21129724
J Clin Neurosci. 2015 Oct;22(10):1625-7
pubmed: 26100160
Cancers (Basel). 2020 Jul 17;12(7):
pubmed: 32708892
Eur J Radiol. 2018 Aug;105:1-7
pubmed: 30017264
Oncotarget. 2017 Jun 27;8(26):43536-43542
pubmed: 28402949
Nat Rev Cancer. 2020 Feb;20(2):89-106
pubmed: 31836838
J Clin Oncol. 2001 Nov 1;19(21):4107-16
pubmed: 11689578
Oncotarget. 2021 Jan 05;12(1):37-48
pubmed: 33456712
Cancer Res. 2017 Nov 15;77(22):6051-6059
pubmed: 29097610
Neoplasia. 2011 Jul;13(7):620-32
pubmed: 21750656
Oral Oncol. 2009 Nov;45(11):963-7
pubmed: 19665923
Oncotarget. 2015 Dec 8;6(39):41582-99
pubmed: 26462158
Biochem J. 2003 Mar 15;370(Pt 3):751-62
pubmed: 12467494
Eur J Nucl Med Mol Imaging. 2014 Mar;41(3):452-61
pubmed: 24081448
Breast Cancer Res Treat. 2011 Jul;128(2):327-36
pubmed: 20697806
Science. 2009 May 22;324(5930):1029-33
pubmed: 19460998
J Clin Invest. 2008 Dec;118(12):3930-42
pubmed: 19033663
Cancers (Basel). 2020 Sep 30;12(10):
pubmed: 33008042
PLoS One. 2013 Jun 14;8(6):e65578
pubmed: 23799027
Cell Metab. 2015 Jan 6;21(1):81-94
pubmed: 25565207
Laryngoscope. 2000 Dec;110(12):2061-5
pubmed: 11129021
Sci Rep. 2017 Oct 18;7(1):13488
pubmed: 29044214
Niger J Clin Pract. 2018 Feb;21(2):163-169
pubmed: 29465049
Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):719-24
pubmed: 15647368
Adv Dent Res. 2011 May;23(2):237-46
pubmed: 21490236
Bioinformatics. 2009 Nov 1;25(21):2744-50
pubmed: 19734154
J Dent Educ. 2001 Apr;65(4):328-39
pubmed: 11336118
J Physiol. 2021 Mar;599(6):1745-1757
pubmed: 33347611
Eur J Cancer Prev. 2013 May;22(3):268-76
pubmed: 22976386
Nat Genet. 2020 Mar;52(3):342-352
pubmed: 32024997
Nat Commun. 2017 Sep 22;8(1):656
pubmed: 28939825
Nat Commun. 2020 Mar 20;11(1):1487
pubmed: 32198407
Int J Mol Sci. 2021 Jan 19;22(2):
pubmed: 33477827
Cancer Lett. 2015 Jan 28;356(2 Pt A):156-64
pubmed: 24732809
J Thorac Oncol. 2008 Jan;3(1):6-12
pubmed: 18166834
Nucleic Acids Res. 2016 Jul 8;44(W1):W64-9
pubmed: 27084948
Eur J Nucl Med Mol Imaging. 2015 Aug;42(9):1353-61
pubmed: 26067088
Dentomaxillofac Radiol. 2019 Jul;48(5):20180416
pubmed: 30794427
Elife. 2017 Feb 15;6:
pubmed: 28195532
PLoS One. 2013;8(1):e53415
pubmed: 23349710
Br J Oral Maxillofac Surg. 1998 Dec;36(6):440-5
pubmed: 9881786
Oncol Res Treat. 2015;38(1-2):45-8
pubmed: 25633888
Science. 1956 Feb 24;123(3191):309-14
pubmed: 13298683

Auteurs

Lukas Latzko (L)

University Hospital for Craniomaxillofacial and Oral Surgery, Medical University of Innsbruck, A-6020 Innsbruck, Austria.

Bernd Schöpf (B)

Institute of Genetic Epidemiology, Department of Genetics and Pharmacology, Medical University of Innsbruck, A-6020 Innsbruck, Austria.

Hansi Weissensteiner (H)

Institute of Genetic Epidemiology, Department of Genetics and Pharmacology, Medical University of Innsbruck, A-6020 Innsbruck, Austria.

Federica Fazzini (F)

Institute of Genetic Epidemiology, Department of Genetics and Pharmacology, Medical University of Innsbruck, A-6020 Innsbruck, Austria.

Liane Fendt (L)

Institute of Genetic Epidemiology, Department of Genetics and Pharmacology, Medical University of Innsbruck, A-6020 Innsbruck, Austria.

Eberhard Steiner (E)

Division of Experimental Urology, Department of Urology, Medical University of Innsbruck, A-6020 Innsbruck, Austria.

Emanuel Bruckmoser (E)

Oral and Maxillofacial Surgeon, Private Practice, A-5020 Salzburg, Austria.

Georg Schäfer (G)

Institute for Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, A-6020 Innsbruck, Austria.

Roy-Cesar Moncayo (RC)

University Hospital of Nuclear Medicine, A-6020 Innsbruck, Austria.

Helmut Klocker (H)

Division of Experimental Urology, Department of Urology, Medical University of Innsbruck, A-6020 Innsbruck, Austria.

Johannes Laimer (J)

University Hospital for Craniomaxillofacial and Oral Surgery, Medical University of Innsbruck, A-6020 Innsbruck, Austria.

Classifications MeSH